Helen M. Thackray, VP Clinical Development, CMO at GLYCOMIMETICS INC (GLYC), sold 10,136 shares at $7.01 ($71K) on 2016-07-05, disclosed to the SEC on 2016-07-06.
Open-market sale of $71k GLYC by VP Clinical Development, CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| BCRX | SELL | 2022-12-19 | $34K | — | Filing → |
| BCRX | SELL | 2022-04-04 | $123K | — | Filing → |
| GLYC | SELL | 2017-12-12 | $30K | — | Filing → |